| | | | | | | |
 | JOHNSON & JOHNSON | 0.99% | 0.51% | -12.88% | -11.98% | 28.36% | 398 260 |
 | NOVO NORDISK A/S | 1.16% | -2.20% | 5.43% | 33.35% | 170.93% | 315 310 |
 | ELI LILLY AND COMPANY | 1.34% | 4.49% | -8.81% | 15.98% | 172.55% | 296 886 |
 | ABBVIE INC. | 1.23% | 3.01% | -3.40% | -1.93% | 126.85% | 272 877 |
 | MERCK & CO., INC. | 1.68% | -3.33% | -4.60% | 33.80% | 48.33% | 264 267 |
 | ROCHE HOLDING AG | -0.11% | -0.72% | -10.00% | -28.66% | -15.13% | 227 903 |
 | PFIZER, INC. | 1.77% | 1.80% | -20.36% | -25.13% | 40.68% | 226 341 |
 | ASTRAZENECA PLC | -0.22% | 1.08% | -3.82% | 13.15% | 56.26% | 203 984 |
 | NOVARTIS AG | 0.66% | 2.17% | -8.19% | -5.00% | 1.37% | 187 199 |
 | BRISTOL-MYERS SQUIBB COMPANY | 1.07% | 1.25% | -6.55% | -5.32% | 38.93% | 139 632 |
 | AMGEN INC. | 2.15% | 0.84% | -10.63% | -0.65% | 24.69% | 122 702 |
 | SANOFI | -0.38% | 0.28% | -0.42% | -4.11% | 17.90% | 119 527 |
 | GILEAD SCIENCES, INC. | 2.78% | -2.75% | -7.44% | 33.73% | 8.46% | 96 414 |
 | GSK PLC | 0.94% | 0.16% | -1.64% | -29.74% | -22.25% | 68 799 |
 | DAIICHI SANKYO CO., LTD. | -1.97% | 3.64% | 5.62% | 86.19% | 117.03% | 66 426 |
| | | | | | | |
| Moyenne | 0.87% | 0.68% | -5.85% | 6.91% | 54.33% | |
| Moyenne pondérée par Capi. | 0.98% | 0.65% | -6.69% | 4.67% | 66.18% | |